Related Experiment Video
Updated: May 16, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Interim treatment selection with a flexible selection margin in clinical trials
1Biostatistics and Programming, Sanofi-Aventis US, Bridgewater, NJ 08807, USA. yujun.wu@sanofi-aventis.com
Statistics in Medicine
|December 6, 2012
Summary
This study introduces a flexible selection rule for clinical trials, allowing more than one promising treatment to advance. This adaptive trial design improves resource efficiency and practicality by considering treatment differences at interim stages.
Area of Science:
- Clinical Trial Design
- Biostatistics
- Pharmaceutical Research
Background:
- Adaptive clinical trial designs aim to improve efficiency by dropping non-promising treatments early.
- Current selection rules often pick only the single best treatment, limiting flexibility.
Purpose of the Study:
- To modify the interim selection rule in adaptive trials for greater flexibility.
- To develop hypothesis testing procedures for assessing selected treatments under the modified rule.
Main Methods:
- Introduced a flexible selection margin to evaluate treatment differences at the interim stage.
- Modified the rule to allow selection of multiple treatments if their effects are similar.
- Developed statistical methods to account for the interim selection process.
Main Results:
- The modified selection rule offers increased flexibility compared to single-winner designs.
- The approach allows for the selection of additional treatments beyond the empirically best one.
- Hypothesis testing procedures were developed to validate selected treatments.
Conclusions:
- The proposed flexible selection margin enhances the practicality of adaptive clinical trial designs.
- This modification allows for more nuanced treatment selection, potentially improving resource allocation.
- The developed methods provide a robust framework for analyzing trials with this adaptive design.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.